Imvax Funding & Investors
Philadelphia, PA
Imvax is a clinical-stage biotechnology company with a unique immunotherapy approach to solid tumors.
imvax.comTotal Amount Raised: $224,694,656
Imvax Funding Rounds
Undisclosed
$35,000,000
Undisclosed
$23,000,000
Series C
$112,000,000
Series C Investors
HP WILD HOLDINGTLP Investment PartnersZiff Capital PartnersInvusMagnetar CapitalSeries B
$40,000,000
Series B Investors
Ziff Capital PartnersMagnetar CapitalWILD Group ManagementSeries A
$14,694,660
Funding info provided by Diffbot.